SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-002263
Filing Date
2012-01-04
Accepted
2012-01-04 17:00:33
Documents
9
Period of Report
2011-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d275141d8k.htm 8-K 19842
2 AGREEMENT AND PLAN OF MERGER d275141dex21.htm EX-2.1 700674
3 JOINT PRESS RELEASE d275141dex991.htm EX-99.1 19232
4 GRAPHIC g275141g27n02.jpg GRAPHIC 362696
5 GRAPHIC g275141g29g42.jpg GRAPHIC 3569
6 GRAPHIC g275141g30a02.jpg GRAPHIC 4886
7 GRAPHIC g275141g44q22.jpg GRAPHIC 378316
8 GRAPHIC g275141g57p78.jpg GRAPHIC 258523
9 GRAPHIC g275141g91m92.jpg GRAPHIC 313428
  Complete submission text file 0001193125-12-002263.txt   2562382
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 12507067
SIC: 2834 Pharmaceutical Preparations